Open AccessTreatment Outcomes in AIDS-Related Diffuse Large B-cell Lymphoma in the Setting Roll Out of Combination Antiretroviral Therapy in South Africa
Author(s) -
Pieter de Witt,
D. Maartens,
Thomas S. Uldrick,
Gerhard Sissolak
Publication year - 2013
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0b013e3182a03e9b
Subject(s) - medicine , vincristine , international prognostic index , chop , tuberculosis , diffuse large b cell lymphoma , prednisone , lymphoma , cyclophosphamide , surgery , chemotherapy , oncology , pathology
Long-term survival for patients with AIDS-related diffuse large B-cell lymphoma (DLBCL) is feasible in settings with available combination antiretroviral therapy (cART). However, given limited oncology resources, outcomes for AIDS-associated DLBCL in South Africa are unknown.